1,6'-DI-N-(L-4-AMINO-2-HYDROXY-BUTYRYL)-KANAMYCIN
Compound with spectra: 1 NMR
| SpectraBase Compound ID | Hm6L5e57Vn3 |
|---|---|
| InChI | InChI=1S/C26H50N6O15/c27-3-1-10(34)23(42)31-9-5-8(30)21(46-26-19(40)18(39)16(37)12(6-29)44-26)20(41)22(9)47-25-17(38)14(15(36)13(7-33)45-25)32-24(43)11(35)2-4-28/h8-22,25-26,33-41H,1-7,27-30H2,(H,31,42)(H,32,43)/t8-,9+,10?,11?,12+,13+,14-,15+,16+,17+,18-,19+,20-,21+,22-,25+,26+/m0/s1 |
| InChIKey | YJEDOCBINAXBLM-MVXRQZJISA-N |
| Mol Weight | 686.7 g/mol |
| Molecular Formula | C26H50N6O15 |
| Exact Mass | 686.333415 g/mol |
| Enantiomer InChIKey | YJEDOCBINAXBLM-UOJKBHOASA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
3''-N-ACETYLAMIKACIN
3''-N-ACETYL-ARBEKACIN
5''-DEOXY-5''-GUANIDINOBUTIROSIN-A
BUTIROSIN-A
1-N-ACETYL-PAROMOMYCIN-1;1-N-ACETYL-PRM
4',5''-DIDEOXY-5''-GUANIDINOYBUTIROSIN-A
METHYL-2-ACETAMIDO-2-DEOXY-4-O-(ALPHA-L-FUCOPYRANOSYL-3-O-[6-O-METHYL-2-O-(ALPHA-L-FUCOPYRANOSYL)-BETA-D-GALACTOPYRANOSYL]-BETA-D-GLUCOPYRANOSIDE;COMPOUN
#1;2-AMINOETHYL-(ALPHA-D-GALACTOPYRANOSYL)-(1->3)-(2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSYL)-(1->2)-(BETA-D-GALACTOPYRANOSYL)-(1->4)-BETA-D-MANNOPYRANOSIDE
8-METHOXYCARBONYLOCTYL-BETA-D-GALACTOPYRANOSYL-(1->4)-2-DEOXY-2-(METHYL-BETA-D-GALACTOHEXOPYRANOSYLURONAMIDE)-BETA-D-GLUCOPYRANOSIDE
8-METHOXYCARBONYLOCTYL-BETA-D-GALACTOPYRANOSYL-(1->4)-2-DEOXY-2-(METHYL-ALPHA-L-GALACTOHEXOPYRANOSYLURONAMIDE)-BETA-D-GLUCOPYRANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| The Identification of 1,6'- and 1,3''-Di-N-(L-4-amino-2-hydroxybutyryl) Derivatives of Kanamycin as Synthetic Byproducts of Amikacin. | The Journal of Antibiotics | 1997 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.